InsiderRadarInsider Alpha EU

Pharming Group N.V.

PHARM.ASHealthcareLEI 724500DCJ9MPG74JEH91

At a glance

  • Most recent filing on June 10, 2026 — a trade by Bernal I. on Jun 5, 2026.
  • Over the past 90 days: 0 open-market buys, and 1 open-market sell.
  • This page shows 93 visible filings, of which 0 open-market buys, going back to September 24, 2021.
Visible filings93
Open-market buys0
Insider score24.8out of 100, most recent scored buy

How the company itself measures up

Four components from the annual figures and the price series, compared with the other companies on the same date. Separate from the filing above, and separate from the question of whether this is a good moment.

Percentile within the universe75

On this measurement the company came out above 75% of the companies measured. That says something about the company's numbers, not about its share price.

Quant score83.0out of 100
Timing12.5technical, out of 100
Data coverage57%how much could be measured

As of Jul 31, 2026 · methodology 0.4.0

ComponentWhat is measuredSub-scoreWeightCompared with
Qualitygross profit relative to total assets97.361%all measured companies
Valuationoperating profit relative to the value of the whole business——not measured — reweighted
Momentumprice return over twelve months, excluding the most recent month60.339%all measured companies
What goes to shareholdersdividends and share buybacks relative to market value——not measured — reweighted

Labels on this measurement: Little could be measured. These are notes about the data. Nothing is subtracted from the score, and it is not a warning about the company.

These figures only mean something in comparison: they take on meaning next to the other companies of that same date. See the full ranking →

Price history and buy moments

0.090.931.76
Adjusted close, Jan 2, 2015 – Jul 31, 2026. Our own price data; source precedence EODHD/Yahoo. Buy markers are delayed by 48 hours, like the rest of the register.

Every visible filing

What was filed, most recent first. On an award the register reports a price of 0 — nothing was paid — and then the Quantity column tells you how large the filing was.

ReportedFiled byRoleCategoryQuantityAmount
Jun 10, 2026Bernal I.Chief People OfficerOpen-market sell126,250€138,875
Apr 6, 2026Bernal I.Chief People OfficerOption exercise125,000nothing paid
Apr 6, 2026Bernal I.Chief People OfficerOption exercise63,125nothing paid
Apr 3, 2026Breidenbach A.Chief Business OfficerOption exercise100,000nothing paid
Apr 3, 2026Breidenbach A.Chief Business OfficerAdministrative50,500nothing paid
Mar 18, 2026Outersterp, van R.Chief Legal & Compliance OfficerOption exercise614,000nothing paid
Mar 18, 2026Outersterp, van R.Chief Legal & Compliance OfficerOption exercise264,087nothing paid
Mar 18, 2026Breidenbach A.Chief Business OfficerOption exercise583,879nothing paid
Mar 18, 2026Breidenbach A.Chief Business OfficerOption exercise251,132nothing paid
Mar 18, 2026Relan A.Chief Medical OfficerOption exercise867,710nothing paid
Mar 18, 2026Relan A.Chief Medical OfficerOption exercise343,550nothing paid
Mar 18, 2026Sanders M.Chief Operations OfficerOption exercise628,347nothing paid
Mar 18, 2026Sanders M.Chief Operations OfficerOption exercise270,258nothing paid
Dec 1, 2025Relan A.Chief Medical OfficerOpen-market sell90,691€136,037
Sep 3, 2025Relan A.Chief Medical OfficerOption exercise337,500nothing paid
Sep 3, 2025Relan A.Chief Medical OfficerOption exercise337,500€320,625
Sep 3, 2025Relan A.Chief Medical OfficerOpen-market sell337,500€421,875
Aug 28, 2025Outersterp, van R.Chief Compliance and Ethics OfficerOption exercise85,000nothing paid
Aug 28, 2025Outersterp, van R.Chief Compliance and Ethics OfficerOption exercise85,000€80,750
Aug 28, 2025Outersterp, van R.Chief Compliance and Ethics OfficerOpen-market sell78,552€91,906
Aug 26, 2025Toor S.Chief Commerfcial OfficerOption exercise23,720nothing paid
Aug 26, 2025Toor S.Chief Commerfcial OfficerAdministrative23,720€22,534
Aug 26, 2025Toor S.Chief Commerfcial OfficerOpen-market sell23,720€25,143
Aug 22, 2025Toor S.Chief Commercial OfficerOption exercise876,280nothing paid
Aug 22, 2025Toor S.Chief Commercial OfficerOption exercise876,280€832,466
Aug 22, 2025Toor S.Chief Commercial OfficerOpen-market sell876,280€928,857
Jun 16, 2025Sanders M.Chief Operations OfficerOption exercise337,500nothing paid
Jun 16, 2025Sanders M.Chief Operations OfficerOption exercise337,500nothing paid
Jun 16, 2025Sanders M.Chief Operations OfficerOpen-market sell331,899€338,537
Apr 4, 2025Bernal I.Chief People OfficerAdministrative125,000nothing paid
Apr 4, 2025Bernal I.Chief People OfficerAdministrative63,125nothing paid
Apr 4, 2025Bernal I.Chief People OfficerAdministrative63,125nothing paid
Mar 17, 2025Toor S.Chief Commercial OfficerAdministrative1,158,768nothing paid
Mar 17, 2025Toor S.Chief Commercial OfficerAdministrative525,153nothing paid
Mar 17, 2025Relan A.Chief Medical OfficerAdministrative1,123,073nothing paid
Mar 17, 2025Relan A.Chief Medical OfficerAdministrative546,178nothing paid
Mar 17, 2025Wakkerman J.Chief Financial OfficerAdministrative1,039,828nothing paid
Mar 17, 2025Wakkerman J.Chief Financial OfficerAdministrative454,111nothing paid
Mar 17, 2025Sanders M.Chief Operations OfficerAdministrative817,264nothing paid
Mar 17, 2025Sanders M.Chief Operations OfficerAdministrative356,914nothing paid
Mar 17, 2025Outersterp, van R.Chief Ethics & Compliance OfficerAdministrative799,150nothing paid
Mar 17, 2025Outersterp, van R.Chief Ethics & Compliance OfficerAdministrative349,003nothing paid
Mar 17, 2025Breidenbach A.Chief Business OfficerAdministrative100,000nothing paid
Mar 17, 2025Breidenbach A.Chief Business OfficerAdministrative50,500nothing paid
Aug 13, 2024Toor S.Chief Commercial OfficerOpen-market sell8,778€6,496
Aug 12, 2024Toor S.Chief Commercial OfficerOpen-market sell178,922€132,402
Aug 6, 2024Sanders M.Chief Operations OfficerOpen-market sell199,458€153,583
Mar 20, 2024Wakkerman J.Chief Financial OfficerOption exercise173,483nothing paid
Mar 20, 2024Wakkerman J.Chief Financial OfficerAward173,483nothing paid
Mar 20, 2024Relan A.Vice President, Clinical Research and Medical AffairsOption exercise184,500nothing paid
Mar 20, 2024Relan A.Vice President, Clinical Research and Medical AffairsAward184,500nothing paid
Mar 20, 2024Outersterp, van R.Chief Ethics & Compliance OfficerOption exercise86,561nothing paid
Mar 20, 2024Outersterp, van R.Chief Ethics & Compliance OfficerAward86,561nothing paid
Mar 20, 2024Sanders M.Chief Operations OfficerOption exercise121,892nothing paid
Mar 20, 2024Sanders M.Chief Operations OfficerAward121,892nothing paid
Mar 20, 2024Toor S.Chief Operations OfficerOption exercise187,700nothing paid
Mar 20, 2024Toor S.Chief Operations OfficerAward187,700nothing paid
Mar 20, 2024Breidenbach A.Chief Business OfficerOption exercise65,350nothing paid
Mar 20, 2024Breidenbach A.Chief Business OfficerAward65,350nothing paid
Aug 25, 2023Sanders M.Chief Operations OfficerOption exercise1,387,500nothing paid
Aug 25, 2023Sanders M.Chief Operations OfficerOption exercise1,387,500€1,082,250
Aug 25, 2023Sanders M.Chief Operations OfficerOpen-market sell971,268€1,107,246
Aug 18, 2023Toor S.Chief Commercial OfficerOption exercise1,000,000nothing paid
Aug 18, 2023Toor S.Chief Commercial OfficerOption exercise1,000,000€730,000
Aug 18, 2023Toor S.Chief Commercial OfficerOpen-market sell1,000,000€1,090,000
Aug 16, 2023Toor S.Chief Commercial OfficerOption exercise99,572nothing paid
Aug 16, 2023Toor S.Chief Commercial OfficerOption exercise99,572€76,670
Aug 16, 2023Toor S.Chief Commercial OfficerOpen-market sell99,572€112,516
Aug 16, 2023Relan A.Chief Medical OfficerOpen-market sell176,757€199,735
Aug 15, 2023Toor S.Chief Commercial OfficerOption exercise313,270nothing paid
Aug 15, 2023Toor S.Chief Commercial OfficerOption exercise313,270€241,218
Aug 15, 2023Toor S.Chief Commercial OfficerOpen-market sell313,270€347,730
Aug 15, 2023Toor S.Chief Commercial OfficerOpen-market sell242,622€271,737
Aug 9, 2023Relan A.Chief Medical OfficerOption exercise450,000nothing paid
Aug 9, 2023Relan A.Chief Medical OfficerOption exercise450,000€369,000
Aug 9, 2023Relan A.Chief Medical OfficerOpen-market sell450,000€508,500
Mar 24, 2023Sanders M.Chief Operations OfficerOption exercise184,199nothing paid
Mar 24, 2023Sanders M.Chief Operations OfficerAward184,199nothing paid
Mar 24, 2023Toor S.Chief Commercial OfficerOption exercise247,738nothing paid
Mar 24, 2023Toor S.Chief Commercial OfficerAward247,738nothing paid
Mar 24, 2023Outersterp, van R.Chief Ethics & Compliance OfficerOption exercise20,074nothing paid
Mar 24, 2023Outersterp, van R.Chief Ethics & Compliance OfficerAward20,074nothing paid
Mar 24, 2023Wakkerman J.Chief Financial OfficerOption exercise180,664nothing paid
Mar 24, 2023Wakkerman J.Chief Financial OfficerAward180,664nothing paid
Mar 24, 2023Relan A.Vice President, Clinical Research and Medical AffairsOption exercise176,757nothing paid
Mar 24, 2023Relan A.Vice President, Clinical Research and Medical AffairsAward176,757nothing paid
Mar 29, 2022Wakkerman J.Chief Financial OfficerOption exercise76,697nothing paid
Mar 29, 2022Outersterp, van R.Chief Ethics & Compliance OfficerOption exercise8,522nothing paid
Mar 29, 2022Toor S.Chief Commercial OfficerOption exercise138,042nothing paid
Mar 29, 2022Friesen R.Chief Scientific OfficerOption exercise38,348nothing paid
Mar 29, 2022Relan A.Vice President, Clinical Research and Medical AffairsOption exercise102,628nothing paid
Mar 29, 2022Sanders M.Chief Operations OfficerOption exercise76,697nothing paid
Sep 24, 2021Outersterp, van R.Chief Ethics & Compliance Officer/member Executive CommitteeAward362,115nothing paid

Follow this company

Loading follow status…

The insider, quant and timing scores stand apart from one another and are meant as context. There is no threshold in them (“above such and such is worth buying”), we do not add them up into a single figure, and none of it is a recommendation. How they are calculated is in the methodology.